Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | HBB | P68871 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | CPA1 | P15085 | 5/20 | 0.41 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.41 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.41 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15451130 | 0.78 | GABRR1 (0.48) | MEN1LMNABLMHBBKMT2A | |
| SCHEMBL3331713 | 0.78 | GABRR1 (0.48) | MEN1LMNABLMHBBKMT2A | |
| SCHEMBL30819096 | 0.77 | MEN1 (0.52) | MEN1LMNABLMHBBKMT2A | |
| SCHEMBL1426861 | 0.75 | BLM (0.41) | MEN1LMNABLMHBBKMT2A | |
| SCHEMBL20659550 | 0.75 | MEN1 (0.41) | MEN1LMNABLMHBBKMT2A | |
| SCHEMBL6231951 | 0.75 | SLC1A3 (0.37) | CPA1SLC1A3SLC1A2SLC1A1ALDH1A1 | |
| SCHEMBL11219301 | 0.73 | MEN1 (0.36) | MEN1LMNABLMHBBKMT2A | |
| SCHEMBL19283718 | 0.72 | MEN1 (0.43) | MEN1LMNABLMHBBKMT2A | |
| SCHEMBL16140111 | 0.72 | SLC1A3 (0.50) | BLMSLC1A3SLC1A2SLC1A1ALDH1A1 | |
| SCHEMBL4292504 | 0.71 | CA2 (0.52) | MEN1LMNABLMHBBKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8637696-B2 | Methods for preparing amides and amino acids | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2014-01-28 | — | — | US | disclosed |
| US-20130030210-A1 | METHODS FOR PREPARING AMIDES AND AMINO ACIDS | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2013-01-31 | — | — | US | disclosed |
| US-8269039-B2 | Amino acids and catalytic preparatory methods | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2012-09-18 | — | — | US | disclosed |
| US-20090264676-A1 | Amino acids and catalytic preparatory methods | WARF - WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2009-10-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130030210-A1 | METHODS FOR PREPARING AMIDES AND AMINO ACIDS | DNPEP, PTMS, QPCT | MEN1 3115/4885LMNA 1848/4885BLM 4418/4885 |
| US-20090264676-A1 | Amino acids and catalytic preparatory methods | DNPEP, PREP, ENPEP | MEN1 3220/4885LMNA 975/4885BLM 3569/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.